Pharmacological treatments are not specific for PD and ... Neuropsychiatric symptoms are well-described nonmotor features of Parkinson's disease (PD). Underdiagnosed and often undertreated ...

After a twitching pinky finger led to a diagnosis of young-onset Parkinson's disease, Keith Krehbiel, then 42, stopped at a ...

With over 10 million people affected worldwide, Parkinson's disease is the fastest-growing neurological disorder. More than ...

T he field of non-pharmacological interventions for the treatment of individuals with Parkinson's disease (PD) is reaching maturity and has the potential to substantially improve patient care in ...

Natalie Elizabeth Allen et al, Pain and the Non-Pharmacological Management of Pain in People with Parkinson's Disease, Journal of Parkinson's Disease (2024). DOI: 10.3233/JPD-230227 Provided by ...

Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...

Experts predict Parkinson's diasesae cases will rise 112% from 2021 to 2050. Learn the symptoms of Parkinson's disease.

Clinical trial tests novel stem-cell treatment for Parkinson's disease. ScienceDaily . Retrieved March 21, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250309203153.htm ...

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD ... may be more prone to treatment-emergent adverse ...

Despite being a mainstay of Parkinson's disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side-effects with long-term use. A recent human trial found that a new drug ...

Scientists have identified a rare genetic mutation in ITSN1 that increases the risk of Parkinson’s disease by up to tenfold, marking one of the most significant genetic discoveries in the field. This ...